InsidersTradesSigma
Corbus Pharmaceuticals Holdings, Inc.: directors' dealings · United States · SEC (Form 4)
SEC:corbus-pharmaceuticals-holdings-inc-5f1beaUS·SEC (Form 4)
Explore the full insider trade history of Corbus Pharmaceuticals Holdings, Inc., a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). The latest transaction was reported on 16 May 2022 (Acquisition). Among the most active insiders: Cohen Yuval. All data is free.
5
Insider Decl.
0
Thresholds
€17,236
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
9.67 €
Analyst consensus
Valuation
P/Book1.2x
Balance sheet & cash
Debt / Equity1%
Profitability & ownership
ROE-66.7%
ROA-39.5%
% insiders0.6%
% institutions71.9%
Last declaration on 16 May 2022
Declarations5 total
Executives▲Purchase◆Signal · 48SEC
€2,51510,500 shares@ €0.239546.3% of flow
Common Stock
SEC:0001209191-22-029030:0·
Ideal exit: 10 Feb 2023 (T+270)
Executives▲Purchase44SEC
€3,44912,000 shares@ €0.287440.8% of flow
Common Stock
SEC:0001209191-22-029031:0·
Ideal exit: 10 Feb 2023 (T+270)
Executives▲Purchase41SEC
€3,34110,000 shares@ €0.3341100.0% of flow
Common Stock
SEC:0001209191-22-018101:0·
Ideal exit: 5 Dec 2022 (T+270)
Executives▲Purchase◆Signal · 47SEC
€5,01215,000 shares@ €0.334159.2% of flow
Common Stock
SEC:0001209191-22-017781:0·
Ideal exit: 5 Dec 2022 (T+270)
Executives▲Purchase◆Signal · 49SEC
€2,9208,600 shares@ €0.339553.7% of flow
Common Stock
SEC:0001209191-22-017449:0·
Ideal exit: 4 Dec 2022 (T+270)
5 of 5 declarations